Furthermore, dioscin was effective in suppressing the TLR4/MyD88/NF-κB signaling pathway to inhibit HSCs activation and reduce ECM accumulation for attenuating liver fibrosis in vivo and in vitro. The gene discussed is MYD88; the disease is Hepatic fibrosis.